Skip to main content

Universal Health Services, Inc. (UHS) Stock Analysis

Falling Knife setup

HoldModerate Confidence

Healthcare · Medical Care Facilities

Hold if already holding. Not a fresh buy at $168.36, but acceptable to hold if already in. Reason: Negative momentum.

Universal Health Services owns and operates 375 inpatient and 168 outpatient facilities across 40 states, the U.K., and Puerto Rico, focused on acute and behavioral healthcare. Revenue is approximately 57% from acute care hospitals and 43% from behavioral health facilities.

$168.36+22.1% A.UpsideScore 5.8/10#6 of 27 Medical Care Facilities
Stop $156.24Target $205.09(analyst − 10%)A.R:R 2.8:1
Analyst target$227.88+35.3%16 analysts
$205.09our TP
$168.36price
$227.88mean
$320

Hold if already holding. Not a fresh buy at $168.36, but acceptable to hold if already in. Reason: Negative momentum. Chart setup: Death cross, below all MAs, RSI 38, MACD bearish. Maintain position. Not compelling to add more. Score 5.8/10, moderate confidence.

Passes 6/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news boost analyst 0.40, earnings proximity 88d clear, semi cycle peak clear). Fails on weak momentum. Suitability: moderate.

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Margin of safety: 53%
Risks
Negative momentum

Key Metrics

P/E (TTM)7.0
P/E (Fwd)6.6
Mkt Cap$10.3B
EV/EBITDA5.8
Profit Mgn8.6%
ROE21.4%
Rev Growth9.6%
Beta1.29
Dividend0.48%
Rating analysts26

Quality Signals

Piotroski F8/9

Options Flow

P/C2.38bearish
IV42%normal
Max Pain$125-25.8% vs spot

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada:...these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024.'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas:...these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024.'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California:...these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024.'

Material Events(8-K, last 90d)

  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and approved a $1.07M discretionary cash bonus for Executive Chairman Alan B. Miller for fiscal 2025. Routine compensatory arrangement.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Ma Position
2.2
Rsi
3.5
Obv
10.0
Volume accumulation (rising OBV)Below 200-MA but MA still rising (+0.1%/30d) — pullback in uptrend, not confirmed weakness
GatesMomentum 3.1<4.5A.R:R 2.8 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS BOOST ANALYST 0.40EARNINGS PROXIMITY 88d clearSEMI CYCLE PEAK CLEARFalling KnifeSuitability: Moderate
RSI
38 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $159.00Resistance $189.45

Price Targets

$156
$205
A.Upside+21.8%
A.R:R2.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Momentum score 3.1/10 — below 4.5 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-27 (88d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Hold if already holding. Not a fresh buy at $168.36, but acceptable to hold if already in. Reason: Negative momentum. Chart setup: Death cross, below all MAs, RSI 38, MACD bearish. Maintain position. Not compelling to add more. Target $205.09 (+21.8%), stop $156.24 (−7.8%), A.R:R 2.8:1. Score 5.8/10, moderate confidence.

What is the UHS stock price target?

Take-profit target: $205.09 (+22.1% upside). Target $205.09 (+21.8%), stop $156.24 (−7.8%), A.R:R 2.8:1. Stop-loss: $156.24.

What are the risks of investing in UHS?

Negative momentum.

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 7.0 (forward 6.6). TrendMatrix value score: 8.5/10. Verdict: Hold.

What do analysts say about UHS?

26 analysts cover UHS with a consensus score of 3.5/5. Average price target: $228.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates 375 inpatient and 168 outpatient facilities across 40 states, the U.K., and...

Universal Health Services owns and operates 375 inpatient and 168 outpatient facilities across 40 states, the U.K., and Puerto Rico, focused on acute and behavioral healthcare. Revenue is approximately 57% from acute care hospitals and 43% from behavioral health facilities.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · ADUS (Addus HomeCare Corporation) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent) · THC (Tenet Healthcare Corporation)